{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T14:31:10Z","timestamp":1781965870419,"version":"3.54.5"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"DOI":"10.3389\/fpubh.2020.00252","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T13:50:13Z","timestamp":1590760213000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":54,"title":["Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review"],"prefix":"10.3389","volume":"8","author":[{"given":"Pattarawadee","family":"Prayuenyong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand V.","family":"Kasbekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Baguley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1001\/jama.2020.4742","article-title":"Treating COVID-19-Off-label drug use, compassionate use, and randomized clinical trials during pandemics","volume":"323","author":"Kalil","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"105938","DOI":"10.1016\/j.ijantimicag.2020.105938","article-title":"New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?","volume":"55","author":"Devaux","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"B5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrobial Agents"},{"key":"B7","doi-asserted-by":"publisher","first-page":"m1432","DOI":"10.1136\/bmj.m1432","article-title":"Chloroquine and hydroxychloroquine in covid-19","volume":"369","author":"Ferner","year":"2020","journal-title":"BMJ."},{"key":"B8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3760\/cma.j.issn.1001-0939.2020.03.009","article-title":"Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia","volume":"43","author":"Jie","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zh"},{"key":"B9","first-page":"601","article-title":"Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide","volume":"15","author":"Cianfrone","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/lio2.65","article-title":"Hearing loss as a risk factor for dementia: a systematic review","volume":"2","author":"Thomson","year":"2017","journal-title":"Laryngoscope Investig Otolaryngol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1093\/geront\/gnz009","article-title":"Hearing loss and depression in older adults: a systematic review and meta-analysis","volume":"60","author":"Lawrence","year":"2019","journal-title":"Gerontologist"},{"key":"B12","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3766\/jaaa.17094","article-title":"Problems and life effects experienced by tinnitus research study volunteers: an exploratory study using the ICF classification","volume":"29","author":"Manchaiah","year":"2018","journal-title":"J Am Acad Audiol"},{"key":"B13","volume-title":"Tinnitus: Clinical and Research Perspectives, 1st ed","author":"Baguley","year":"2016"},{"key":"B14","first-page":"14","article-title":"Assessment of short term chloroquine-induced ototoxicity in malaria patients","volume":"15","author":"Subramaniam","year":"2015","journal-title":"Global J Med Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s10067-007-0662-6","article-title":"Chloroquine ototoxicity","volume":"26","author":"Bortoli","year":"2007","journal-title":"Clin Rheumatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1191\/0961203304lu528oa","article-title":"Chloroquine gestational use in systemic lupus erythematosus: assessing the risk of child ototoxicity by pure tone audiometry","volume":"13","author":"Borba","year":"2004","journal-title":"Lupus"},{"key":"B17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0194-5998(96)70226-7","article-title":"Chloroquine ototoxicity: an idiosyncratic phenomenon","volume":"114","author":"Hadi","year":"1996","journal-title":"Otolaryngol Head Neck Surg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3109\/00016488509108928","article-title":"Alterations of auditory evoked potentials during the course of chloroquine treatment","volume":"99","author":"Bernard","year":"1985","journal-title":"Acta Otolaryngol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1017\/S0022215100087740","article-title":"Chloroquine ototoxicity\u2013a reversible phenomenon?","volume":"93","author":"Mukherjee","year":"1979","journal-title":"J Laryngol Otol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1017\/S0022215100085960","article-title":"Ototoxicity of chloroquine phosphate","volume":"92","author":"Dwivedi","year":"1978","journal-title":"A Case Report J Laryngol Otol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/archotol.1968.00770010372008","article-title":"Ototoxicity of chloroquine","volume":"88","author":"Matz","year":"1968","journal-title":"Arch Otolaryngol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/archotol.1964.00750040419009","article-title":"The ototoxicity of chloroquine phosphate","volume":"80","author":"Hart","year":"1964","journal-title":"Arch Otolaryngol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S0140-6736(54)92747-6","article-title":"Chloroquine in lupus erythematosus","volume":"263","author":"Dewar","year":"1954","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1590\/abd1806-4841.20187615","article-title":"Hydroxychloroquine ototoxicity in a patient with systemic lupus erythematosus","volume":"93","author":"Fernandes","year":"2018","journal-title":"An Bras Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2008-2231-22-20","article-title":"A case report of hearing loss post use of hydroxychloroquine in a HIV-infected patient","volume":"22","author":"Khalili","year":"2014","journal-title":"Daru"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1756-185X.2010.01582.x","article-title":"Hydroxychloroquine-induced ototoxicity in a child with systemic lupus erythematosus","volume":"14","author":"Lim","year":"2011","journal-title":"Int J Rheum Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0165-5876(01)00592-4","article-title":"Hydroxychloroquine ototoxicity in a child with idiopathic pulmonary haemosiderosis","volume":"62","author":"Coutinho","year":"2002","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s002960000054","article-title":"Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis","volume":"19","author":"Seckin","year":"2000","journal-title":"Rheumatol Int"},{"key":"B29","first-page":"472","article-title":"Ototoxicity due to hydroxychloroquine: report of two cases","volume":"16","author":"Johansen","year":"1998","journal-title":"Clin. Exp. Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5539\/gjhs.v5n5p102","article-title":"Hearing loss in patients with systemic lupus erythematosus","volume":"5","author":"Abbasi","year":"2013","journal-title":"Glob J Health Sci."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmrp.2020.04.001","article-title":"An overview of coronaviruses including the SARS-2 coronavirus - Molecular biology, epidemiology and clinical implications","author":"Kaul","year":"2020","journal-title":"Curr Med Res Pract"},{"key":"B32","doi-asserted-by":"publisher","first-page":"106003","DOI":"10.1117\/1.JBO.17.10.106003","article-title":"Effects of hypoxia on cochlear blood flow in mice evaluated using Doppler optical microangiography","volume":"17","author":"Dziennis","year":"2012","journal-title":"J Biomed Opt"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa114","article-title":"COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression","author":"Zhou","year":"2020","journal-title":"J Antimicrob Chemother"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpubh.2020.00252\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T13:50:15Z","timestamp":1590760215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpubh.2020.00252\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":33,"alternative-id":["10.3389\/fpubh.2020.00252"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2020.00252","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]},"article-number":"252"}}